Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||||
| Cash from operating activities | -33.15%592.6M | 91.44%886.45M | -33.03%463.05M | 47.95%691.46M | -43.09%467.37M | -6.93%821.3M | 882.49M |
| Net profit before non-cash adjustment | 36.00%573.79M | -32.11%421.9M | -1.74%621.42M | -13.30%632.39M | 63.75%729.43M | -5.06%445.44M | --469.18M |
| Total adjustment of non-cash items | -4.21%562.51M | 857.53%587.22M | -138.16%-77.52M | 183.30%203.13M | -75.66%71.7M | -31.21%294.61M | --428.28M |
| -Depreciation and amortization | 3.55%349.33M | 28.45%337.36M | 33.85%262.65M | 5.01%196.22M | -17.33%186.86M | -5.52%226.03M | --239.25M |
| -Disposal profit | -90.32%8.26M | 751.03%85.27M | -76.72%10.02M | 6,751.59%43.03M | -97.31%628K | -26.75%23.32M | --31.83M |
| -Net exchange gains and losses | ---- | ---- | ---- | ---- | ---- | 132.14%36K | ---112K |
| -Other non-cash items | 24.50%204.92M | 147.00%164.59M | -869.42%-350.19M | 68.80%-36.12M | -355.99%-115.79M | -71.25%45.23M | --157.32M |
| Changes in working capital | -343.22%-543.7M | -51.72%-122.67M | 43.88%-80.85M | 56.84%-144.06M | -510.84%-333.76M | 642.74%81.24M | ---14.97M |
| -Change in receivables | -326.13%-181.48M | 58.50%80.25M | 427.62%50.63M | 93.21%-15.45M | -316.81%-227.59M | 195.54%104.97M | ---109.87M |
| -Change in inventory | -892.87%-138.6M | 90.02%-13.96M | -78.11%-139.91M | -81.91%-78.55M | -29.46%-43.18M | -193.95%-33.36M | --35.5M |
| -Change in payables | -20.46%-212.85M | -753.42%-176.7M | 169.38%27.04M | -34.26%-38.98M | -129.00%-29.03M | 1,029.48%100.11M | ---10.77M |
| -Provision for loans, leases and other losses | 12.09%-10.78M | 34.14%-12.26M | -68.07%-18.62M | 67.38%-11.08M | 62.47%-33.96M | -228.95%-90.49M | --70.17M |
| Dividends paid (cash flow from operating activities) | |||||||
| Dividends received (cash flow from operating activities) | |||||||
| Interest paid (cash flow from operating activities) | -17.92%-35.17M | -71.69%-29.83M | -17.05%-17.37M | 9.96%-14.84M | 31.99%-16.48M | 10.01%-24.24M | -26.93M |
| Interest received (cash flow from operating activities) | 42.11%4.48M | 27.33%3.15M | 9.41%2.48M | -19.72%2.26M | -3.33%2.82M | -64.29%2.92M | 8.17M |
| Tax refund paid | -9.13%-95.34M | 54.96%-87.37M | 18.37%-193.96M | -128.37%-237.61M | 63.83%-104.04M | -36.87%-287.67M | -210.18M |
| Other operating cash inflow (outflow) | -95.06%15.24M | 30.18%308.27M | 272.10%236.8M | 63.64M | 0 | -25.78%6.52M | 8.79M |
| Operating cash flow | -55.42%481.8M | 120.10%1.08B | -2.76%490.99M | 44.40%504.91M | -32.61%349.66M | -21.67%518.83M | --662.34M |
| Investing cash flow | |||||||
| Net PPE purchase and sale | 79.99%-271.36M | 28.57%-1.36B | -140.21%-1.9B | -381.39%-790.37M | 31.22%-164.19M | -831.33%-238.72M | --32.64M |
| Net intangibles purchase and sale | -147.04%-62.96M | -441.91%-25.49M | 34.62%-4.7M | 51.91%-7.19M | 45.68%-14.96M | 54.74%-27.53M | ---60.83M |
| Net investment product transactions | 3.62%-1.25M | 88.40%-1.3M | -831.78%-11.2M | -113.21%-1.2M | 858.80%9.1M | 80.97%-1.2M | ---6.3M |
| Net changes in other investments | 100.00%-2K | -233.74%-85.26M | -11.58%-25.55M | -572,275.00%-22.9M | -100.03%-4K | 126,608.33%15.18M | ---12K |
| Investing cash flow | 77.14%-335.57M | 24.32%-1.47B | -136.11%-1.94B | -383.19%-821.66M | 32.59%-170.05M | -631.18%-252.27M | ---34.5M |
| Financing cash flow | |||||||
| Net issuance payments of debt | -85.24%103M | -37.68%698M | 423.11%1.12B | -1,915.65%-346.63M | -101.40%-17.2M | 257.81%1.23B | ---776.35M |
| Net common stock issuance | -61.57%-24.28M | 59.81%-15.03M | -103.22%-37.4M | --1.16B | ---- | ---1.52B | --0 |
| Cash dividends paid | -3.07%-131.22M | 23.00%-127.31M | ---165.34M | ---- | ---- | ---- | ---- |
| Net other fund-raising expenses | 24.15%-3M | 84.21%-3.96M | 22.33%-25.07M | -538.90%-32.27M | 36.52%-5.05M | 69.73%-7.96M | ---26.29M |
| Financing cash flow | -110.06%-55.5M | -38.16%551.71M | 14.01%892.2M | 3,617.29%782.53M | 92.57%-22.25M | 62.67%-299.62M | ---802.64M |
| Net cash flow | |||||||
| Beginning cash position | 33.36%656.33M | -53.08%492.16M | 79.87%1.05B | 36.96%583.19M | -7.20%425.82M | -27.59%458.88M | --633.69M |
| Current changes in cash | -44.74%90.73M | 129.48%164.17M | -219.54%-556.81M | 195.98%465.78M | 576.02%157.37M | 81.09%-33.06M | ---174.81M |
| Cash adjustments other than cash changes | ---- | -200.00%-1K | 0.00%1K | 200.00%1K | 0.00%-1K | 0.00%-1K | ---1K |
| End cash Position | 13.82%747.06M | 33.36%656.33M | -53.08%492.16M | 79.87%1.05B | 36.96%583.19M | -7.20%425.82M | --458.88M |
| Free cash flow | 148.65%146.49M | 78.68%-301.13M | -382.58%-1.41B | -271.62%-292.65M | -32.35%170.52M | -51.21%252.08M | --516.64M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |